|
|
FDADocs 5/9/2008 | 0 (0) | 22 | 0 | 0 | English
ERRATA TO FDA BRIEFING DOCUMENT
1.
The following items in the briefing document need to be corrected. Deletions are indicated by strikethrough and corrections are in italics.
• •
Page 7, last sentence, paragraph 3: PBSA replaced by S. aureus bacteremia. Page 11, last sentence: It is noteworthy that only 44% of all study patients completed treatme ... more>>
FDADocs 5/9/2008 | 0 (0) | 31 | 0 | 0 | English
Case 8:03-cv-01663-RAL-MSS
Document 64
Filed 09/14/2004
Page 1 of 13
UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA TAMPA DIVISION UNITED STATES OF AMERICA, Plaintiff, v. PHARMAKON LABORATORY, INC., a Corporation; and ABELARDO L. ACEBO and EDWARD R. JACKSON, individuals, Defendants. _________________________________/ CASE NO. 8:03-cv-2 ... more>>
larryp 11/4/2008 | 0 (0) | 1 | 0 | 0 | English
FDADocs 5/8/2008 | 0 (0) | 12 | 0 | 0 | English
History Corner
History Corner
With permission from FDLI www.fdli.org
FDA’s Yearly Project Plan: “Its Principal Virtue Being an Obviation of Vagueness”
he Food and Drug Administration’s (FDA’s) Centennial also is the centennial of the “invention” of the federal food and drug inspector. The Bureau of Chemistry employed scientists from its inception ... more>>
FDADocs 5/9/2008 | 0 (0) | 18 | 0 | 0 | English
FDADocs 5/9/2008 | 0 (0) | 15 | 0 | 0 | English
FDADocs 5/9/2008 | 0 (0) | 20 | 0 | 0 | English
FDA/CFSAN/OPA: Agency Response Letter : GRAS Notice No. GRN 000061
Page 1 of 3
4111
U. S. Food and Drug Administration Center for Food Safety & Applied Nutrition
Office of I'remarket Approval
Agency Response Letter GRAS Notice No. GRN 000061
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
Food and Drug Administration Washington, DC ... more>>
FDADocs 5/5/2008 | 0 (0) | 9 | 0 | 0 | English
FDADocs 5/9/2008 | 0 (0) | 39 | 0 | 0 | English
FDA Executive Summary Prepared for the November 9, 2006 Dental Products Panel Company: Device: Document No.: Date: Medtronic Sofamor Danek InFuse® Bone Graft P050053 October 4, 2006
InFuse® Bone Graft is a combination product consisting of a device and a biologic drug. FDA has determined that InFuse® will be reviewed as a PMA device/drug with cons ... more>>
FDADocs 5/9/2008 | 0 (0) | 36 | 0 | 0 | English
FDA/CFSAN/OPA : Agency Response Letter : GRAS Notice No. GRN 000053
Page l of 3
4
0
U. S. Food and Drug Administration Center for Food Safety & Applied Nutrition
Office of Premarket Approval
Agency Response Letter GRAS Notice No. GRN 000053
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
Food and Drug Administration Washington, DC ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 48 | 0 | 0 | English
Guidance for Industry and FDA Staff
Guidance Document for Vascular Prostheses 510(k) Submissions
Document issued on: November 1, 2000
This document supercedes Guidance Document for Vascular Prostheses 510(k) Submissions; Final, 11/26/1999
U.S. Department Of Health and Human Services Food and Drug Administration Center for Devices and Radiologica ... more>>
FDADocs 5/9/2008 | 0 (0) | 13 | 0 | 0 | English
Immunogenicity and Product Quality Attributes
Point
Immunogenicity of protein products cannot be predicted by biochemical/analytical techniques alone.
– Comparative, side-by-side testing is needed – Up-to-date methods should be used
Counterpoint
The more like the innovator, the less immunogenicity testing is needed pre-marketing
Factors which can ... more>>
FDADocs 5/9/2008 | 0 (0) | 34 | 0 | 0 | English
Draft Guidance for Industry and FDA Staff: Whole Grains Label ~'taternents Docket No. 2006D-0066 References for Draft Guidance Tab I- 1 . U.S . Department of IJealtlh and Human Services and U .S . Department of Agriculture, "Dietary Guidelines for Americans, 2005q'° _I aAVW .b ea lt,hierus .-c>v/c~Yt,tar i.deli ncs, 2005 . Tab J - 2 . 1-loseney, R. ... more>>
FDADocs 5/9/2008 | 0 (0) | 35 | 0 | 0 | English
FDA Executive Summary (Version 2) Prepared for the March 27, 2006, meeting of the Obstetrics & Gynecology Devices Panel P050011 Innovata plc ® Adept Adhesion Reduction Solution (4% Icodextrin Solution)
1.) INDICATIONS FOR USE
Adept Adhesion Reduction Solution (4% Icodextrin Solution) (Adept®) is intended for use as an adjunct to good surgical techn ... more>>
FDADocs 5/9/2008 | 0 (0) | 28 | 0 | 0 | English
" S
SERwICP~~U~
. .
.
.
.
. .
.
.. .
. .
. . .
,
_ .
.. .
. .
.
.
..
. .
. .
.
. .
. .
. .
..
.
. .
. .
.
.
.
o
"`"e~a
, ( ti+
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration Rockvilie MD 20857
:
Bruce S. Manheim, Jr. Ropes & Gray LLP One Metro Center Suite 900; 700 126' S ... more>>
| | | |
| results / page 15/25/50 |
Page: 30 of 34
|
...3034
|
|